Altimmune

Altimmune is a clinical-stage biopharmaceutical company that develops and commercializes immunotherapeutics for the treatment of infectious diseases. Read more

Vipin K. Garg's photo - President & CEO of Altimmune

President & CEO

Vipin K. Garg

CEO Approval Rating

78/100

Founded:

1997

Status:

PublicIndependent CompanyNASDAQALT

ALTIMMUNE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Selecta Biosciences is Altimmune's #1 competitor. Selecta Biosciences was founded in Watertown, Massachusetts} in 2007. Like Altimmune, Selecta Biosciences also competes in the Pharmaceuticals industry. Compared to Altimmune, Selecta Biosciences generates $7.5M more revenue.

Inovio is one of Altimmune's top competitors. Inovio was founded in 1979 in Plymouth Meeting, Pennsylvania. Like Altimmune, Inovio also operates in the Pharmaceuticals industry. Inovio generates $1.7M less revenue than Altimmune.

VBI Vaccines is a top competitor of Altimmune. VBI Vaccines was founded in 2001, and is headquartered in Cambridge, Massachusetts. Like Altimmune, VBI Vaccines also competes in the Pharmaceuticals field. VBI Vaccines generates $293.5M more revenue vs. Altimmune.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is United Biomedical, Inc. a competitor of Altimmune?

Altimmune Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$8.2M

Altimmune's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 63M. Over the last three quarters, Altimmune's revenue has grown by 527.1%. Specifically, in Q4 2020's revenue was $4.5M; in Q3 2020, it was $2.9M; in Q2 2020, it was $ < 1M.

Altimmune Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Spitfire Pharma, Inc.

Jul 2019

Source »
$5M
-

These are all the companies that Altimmune has acquired. Altimmune's latest acquisition was Spitfire Pharma, Inc. in Jul 2019.

Altimmune Funding History

Since Altimmune was founded in 1997, it has participated in 6 rounds of funding. In total Altimmune has raised $59.4M. Altimmune's last funding round was on Jun 2020 for a total of $4.7M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Grant
Jun 2020
$4.7M
Debt - PPP (CARES Act)
Apr 2020
$632K
-
Debt - PPP (CARES Act)
Apr 2020
$350K - $1M

U.S. Small Business Administration.

Grant
Aug 2019
$3.7M
-
Equity
Mar 2015
$42M
-

Since Altimmune was founded in 1997, it has participated in 6 rounds of funding. In total Altimmune has raised $59.4M. Altimmune's last funding round was on Jun 2020 for a total of $4.7M

Altimmune Investments

No recent investments found related to Altimmune

These are all the companies that Altimmune has invested in. Altimmune's latest investment was Spitfire Pharma, Inc. in Jul 2019.

Altimmune News

May 27, 2021Markets Insider

Altimmune to Present at the 2021 Jefferies Virtual Healthcare Conference

GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage b... See more »
May 17, 2021Benzinga

Looking Into Altimmune's Return On Capital Employed

During Q1, Altimmune's (NASDAQ:ALT) reported sales totaled $837.52 thousand. Despite a 38.25% in earn... See more »
May 17, 2021Zacks

Altimmune, Inc. (ALT) Reports Q1 Loss, Misses Revenue Estimates

Altimmune, Inc. (ALT) delivered earnings and revenue surprises of 2.56% and -61.74%, respectively, fo... See more »

Altimmune Press Releases

March 15, 2021GlobeNewswire

AdCOVID , Altimmune's Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection

New Findings from Ongoing Collaborations with University of Alabama at Birmingham and Saint Louis Uni... See more »
March 8, 2021GlobeNewswire

Altimmune to Present at Upcoming Conferences

GAITHERSBURG, Md., March 08, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage... See more »
January 12, 2021NewsFile

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT

New York, New York--(Newsfile Corp. - January 11, 2021) - Pomerantz LLP is investigating claims on be... See more »
January 5, 2021centralcharts

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. -... See more »
August 7, 2020GlobeNewswire

Altimmune Completes Enrollment in Phase 1b Clinical Trial of NasoShield , a Single Dose Intranasal Anthrax Vaccine Candidate

GAITHERSBURG, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage ... See more »
June 30, 2020GlobeNewswire

Altimmune Announces Dosing of First Patient in Phase 1b Clinical Trial of NasoShield , a Single Dose Intranasal Anthrax Vaccine Candidate

GAITHERSBURG, Md., June 30, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage ... See more »
June 22, 2020centralcharts

Altimmune Announces IND Clearance for a Phase 2 Trial of HepTcell Immunotherapeutic for the Treatment of Chronic Hepatitis B

GAITHERSBURG, Md., June 22, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage ... See more »

Social Media

Altimmune Headquarters

910 Clopper Road Suite 201S

Gaithersburg, Maryland20878

240-654-1450

Driving Directions »

Trending Companies

Altimmune Summary

ABOUT

Overview

Altimmune is a clinical-stage biopharmaceutical company that develops and commercializes immunotherapeutics for the treatment of infectious diseases. Altimmune was founded in 1997. Altimmune's headquarters is located in Gaithersburg, Maryland, USA 208...

CEO

Altimmune's President & CEO, Vipin K. Garg, currently has an approval rating of 78%. Altimmune's primary competitors are Selecta Biosciences, Inovio & VBI Vaccines.

Frequently Asked Questions about Altimmune

  1. When was Altimmune founded?

    Altimmune was founded in 1997
  2. Who is Altimmune's CEO?

    Altimmune's CEO is Vipin K. Garg
  3. How much revenue does Altimmune generate?

    Altimmune generates $8.2M in revenue
  4. How much funding does Altimmune have?

    Altimmune has historically raised $59.4M in funding
  1. Where is Altimmune's headquarters?

    Altimmune's headquarters is in Gaithersburg Maryland, USA
  2. How many employees does Altimmune have?

    Altimmune has 27 employees
  3. What sector does Altimmune operate in?

    Altimmune is in Pharmaceuticals
  4. Who are Altimmune's competitors?

    Altimmune's top competitors are Selecta Biosciences, Inovio, VBI Vaccines